Drug Trial Radar · NCT07490496
Phase 3 Bunionectomy Study
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
112
Planned (sponsor's estimate)
Start
Mar 1, 2027
Primary completion
Jun 30, 2027
Study completion Aug 30, 2027
Sponsor
- Lead sponsor
- Cali Pharmaceuticals LLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.
Conditions
- Postoperative Pain
- Bunion
Interventions
CPL-01Drug
Administration by the Surgeon during the operation
saline placeboDrug
Administration by the Surgeon during the operation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Postoperative Pain with activityTime frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CenExel
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.